Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Fact-checking 5 misleading claims about Helene relief efforts
Recommended
NC elections upended by Helene: Voting could be delayed, ballots might be lost. Here's what you need to know
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Iterum Therapeutics plc
Iterum Therapeutics Reports Employment Inducement Grant
January 11, 2023
From
Iterum Therapeutics plc
Via
GlobeNewswire
Tickers
ITRM
Iterum Therapeutics announces Issuance of Allowance for a U.S. Patent Covering Oral Sulopenem
December 15, 2022
From
Iterum Therapeutics plc
Via
GlobeNewswire
Tickers
ITRM
Iterum Therapeutics Reports Third Quarter 2022 Financial Results
November 10, 2022
From
Iterum Therapeutics plc
Via
GlobeNewswire
Tickers
ITRM
Iterum Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial Results on November 10, 2022
November 03, 2022
From
Iterum Therapeutics plc
Via
GlobeNewswire
Tickers
ITRM
Iterum Announces First Patient Dosed in REASSURE, a Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections
October 20, 2022
From
Iterum Therapeutics plc
Via
GlobeNewswire
Tickers
ITRM
Iterum Therapeutics to Present Data at IDWeek 2022
October 17, 2022
From
Iterum Therapeutics plc
Via
GlobeNewswire
Tickers
ITRM
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.